UFRF files lawsuit against Diamyd Medical

NewsGuard 100/100 Score
Feb 11 2011

The University of Florida Research Foundation Inc. (UFRF) has filed a lawsuit in United States federal district court in Florida against Diamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY) claiming that UFRF is entitled to a percentage of the license fee paid to Diamyd Medical by Ortho-McNeil-Jansen Pharmaceuticals, Inc. (OMJPI). Diamyd Medical has licensed certain rights from UFRF, and these rights were among the rights that Diamyd Medical sublicensed to OMJPI. Diamyd Medical is working with its U.S. legal counsel to settle this matter.

The outcome of this matter is deemed not to have a material impact on Diamyd Medical.

SOURCE Diamyd Medical

Posted in: Business / Finance

Tags: , , , , ,

Comments (0)

Suggested Reading

Rising antibiotic resistance prompts shift to ecological research strategies in infection control
Do you wear makeup while you exercise? New research reveals the effects on skin and pores
Diet's role in fighting vitiligo highlighted in new research
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies
Research from NY highlights pollution as a key factor in rising cancer rates among youth
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses
Expanding research and clinical options for children with cancer
Microfluidic chips advance neurodegenerative disease research

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Research explores the health benefits of resistant starch in plant-based diets